51 results about "Diabetic heart" patented technology

The present system combines image morphing technology, exercise programming, supplement sales, and motivational techniques into one product. Users begin by entering their current measurements, measurement goals and current picture into the system, preferably via a Web site. The picture is segmented into body components, and each affected segment is morphed based upon the measurements, goals, and the segment's responsiveness to weight loss in order to create a modified image representative of the user in a post-regimen condition. This system helps health and fitness businesses obtain new members and retain existing members by showing the members how they will look after following a specific regimen of diet and/or exercise. The system also predicts health risks of diabetes, heart disease, and stroke associated with the user's pre-regimen and post-regimen conditions.

The present invention discloses and claims various interproximal devices and associated methods for: (a) removing and disrupting interproximally, supragingival and subgingivally the microbiological burden associated with biofilms, (b) controlling biofilm influence among at risk adults on certain systemic chronic diseases including: Type II diabetes, heart disease, atherosclerosis, myocardial infarction and osteoporosis, and (c) maintaining periostasis in at risk adults.

The present invention discloses for the first time that the insulin receptor (IR) is a target of Herstatin, which modulates IR and IR-mediated intracellular signaling. In preferred aspects, Herstatin binds at nM concentrations to cell-surface IR, up-regulates basal IR expression by several-fold, induces the accumulation of pro-IR, and stimulates insulin activation of the ERK pathway. Moreover, these changes in insulin signaling are accompanied by alterations in IGF-IR expression, IRS-2 levels, and the serine phosphorylation state of both IRS-1 and IRS-2. Preferred aspects provide novel therapeutic methods and pharmaceutical compositions for treatment of conditions associated with altered IR expression or IR-mediated signaling, including but not limited to insulin resistance syndrome, pre-diabetic conditions, metabolic syndrome, type 1 and type 2 diabetes, cardiac disease, diabetes-associated vascular disease, atherosclerosis, hypertension, diabetes-associated lipid metabolism disorders (dyslipidemia), obesity, critical illness, neurodegenerative disorders, and combinations thereof, and cancer.

The invention provides berberine and panax notoginseng saponins and use of a composition using berberine and panax notoginseng saponins as effective components in preparing medicines for preventing and treating diabetes mellitus and complications thereof. The complications of diabetes mellitus are selected from diabetic cardiac abnormalities, diabetic renal lesions, diabetic retinopathy, diabetic peripheral neuropathy and diabetic vasculopathy.

The invention discloses a Chinese materia medica preparation for treating diabetic heart disease, and belongs to the field of traditional Chinese medicines. The Chinese materia medica preparation for treating the diabetic heart disease is made of the following bulk drugs, by part of weight, rhizoma anemarrhenae 9, pseudo-ginseng 12, the root of red-rooted salvia 12, mangnolia officinalis 8, paeonia suffruticosa 8, angelica sinensis 6, schisandra chinensis 9, lignum dalbergiae odoriferae 10, cape jasmine fruit 10, platycladi seed 8, radix asparagi 9, trichosanthes kirilowii maxim 9, dogwood 6, immature bitter orange 9 and herba epimedii 8. According to the Chinese materia medica preparation for treating the diabetic heart disease, natural traditional Chinese medicines are used as raw materials, curative effects are good, toxic and side effects do not exist, and a total effective rate for treating the diabetic heart disease reaches 97%.

The invention relates to a traditional Chinese medicine for treating diabetic heart disease, belonging to the field of traditional Chinese medicine for treating diabetic and aiming at having the advantages good effect and high effect taking speed. The traditional Chinese medicine for treating diabetic heart disease is prepared from raw materials such as lignum dalbergiae odoriferae, the fruit of Chinese wolfberry, pseudo-ginseng, lucid ganoderma, red-rooted salvia root and the like. The traditional Chinese medicine for treating diabetic heart disease has the functions of strengthening the body resistance, invigorating qi to nourish the blood, promoting blood circulation and removing blood stasis, promoting coronary circulation and relieving pain, and has the advantages of remarkable effect, accurate medicine effect and higher effect taking speed.

The invention provides a Chinese medicine composition capable of effectively treating diabetic heart disease, belonging to the field of Chinese medicines. The Chinese medicine composition for treating diabetic heart disease is characterized by being prepared from the Chinese medicinal herbs in parts by weight: 12 parts of kudzu vine root, 12 parts of citrus chirocarpus, 20 parts of American ginseng, 15 parts of cassia twig, 15 parts of semen lepidii, 10 parts of white mulberry root bark, 8 parts of lignum dalbergiae odoriferae, 8 parts of rhizoma corydalis, 12 parts of safflower carthamus, 10 parts of flos rosae rugosae, 12 parts of arillus longan, 15 parts of concha margaritiferallsta, 25 parts of hawthorn leaf, 12 parts of sandalwood, 15 parts of tuber fleeceflower root and 20 parts of spina date seed. The Chinese medicine composition is prepared from natural Chinese medicinal herbs as raw materials, is used for treating the diabetic heart disease by using combined action of all Chinese medicinal herbs, has no toxic and side effects to a human body, and has the advantages of low cost and accurate treatment effect. In 50 patients in clinical tests, the Chinese medicine composition takes the effect in 35 patients, has the effect in 11 patients, and has no effects in 4 patients, thus the total effective rate is 96 percent.

The invention discloses a traditional Chinese medicine for treating diabetic heart disease and belongs to the field of traditional Chinese medicines for treating diabetes. The invention aims to provide a traditional Chinese medicine which has remarkable effect and quick effectiveness. The traditional Chinese medicine is prepared from the following raw materials: gardenia, Chinese angelica, pseudo-ginseng root, cynanchum atratum, lucid ganoderma and Salvia miltiorrhiza Bunge. The traditional Chinese medicine has effects of strengthening health qi, cultivating source, tonifying qi and blood, replenishing the vital essence, removing heat and promoting blood circulation and removing blood stasis, and has the advantages of remarkable treatment effect, exact medicament effect and quick effectiveness.

The invention discloses Application of sodium houttuyfonate in preparation of products for prevention and treatment of diabetic cardiopathy. Houttuyfonate sodium can be use for preparing product for preventing and treating diabetic heart disease, regulating myocardial energy metabolism disorder, and improving glycolipid metabolism abnormality. The invention has been proved by experiments that: (1)sodium houttuyfonate has preventive and therapeutic effects on diabetic heart disease and cardioprotective effects; (2) It can regulate the disturbance of myocardial energy metabolism; (3) It can reduce the increase of blood lipid caused by diabetes mellitus and has the effect of lowering blood glucose. It has good clinical application prospect in the prevention and treatment of diabetes-inducedcardiac injury, myocardial energy metabolism disorder, glucose and lipid metabolism abnormalities and so on.

The invention discloses a traditional Chinese medicine for treating diabetic heart disease, belonging to the field of traditional Chinese medicines for treating diabetes and aiming at achieving favorable effect and quick response. The traditional Chinese medicine is prepared from nutgrass galingale rhizome, Chinese angelica, panaxnotoginseng, cynanchum atratum, glossy ganoderma, the root of red-rooted salvia and other raw materials and has the functions of centralizing and cultivating the body, invigorating qi and nourishing blood, replenishing the vital essence and removing heat and activating blood circulation to dissipate blood stasis as well as the advantages of remarkable effect, definite medicine effect and quicker response.

The invention provides a traditional Chinese medicine compound medicine consisting of coptis chinensis, astragalus membranaceus, pseudo-ginseng and rehmannia and an application of the traditional Chinese medicine compound medicine to prevention and treatment of diabetes mellitus and diabetes mellitus complications. The compound medicine disclosed by the invention has good prevention and treatment effects on various diabetic complications such as diabetes mellitus, diabetic heart diseases, diabetic kidney diseases and diabetic retinopathy.

The invention relates to a traditional Chinese medicine for treating diabetic heart disease, and belongs to the field of traditional Chinese medicines for treating diabetes mellitus. The traditional Chinese medicine aims to achieve good effect and quick response, and is prepared from finger citron, Chinese angelica, notoginseng root, blackend swallowwort root, glossy ganoderma, root of red-rooted salvia and the like serving as raw materials. The traditional Chinese medicine has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, nourishing yin and clearing away heat and promoting blood circulation by removing blood stasis, and has the advantages of obvious effect, definite curative effect and quick response.

A traditional Chinese medicine for treating diabetic heart disease belongs to the field of the traditional Chinese medicine for treating diabetes, and aims at good and quick effect. The traditional Chinese medicine is prepared from jasmine, barbary wolfberry fruit, rosewood heart wood, pseudo-ginseng, salvia mitiorrhiza, lucid ganoderma and other raw materials, and has the functions of strengthening healthy energy, tonifying kidney, reinforcing qi, nourishing blood, promoting circulation, removing stasis, dredging vessels and eliminating pain, and advantages of obvious effect, accurate efficacy and quicker effect.

A pharmaceutical composition for repairing diabetic heart disease. The composition contains ester-type catechin (EGCG) and fat stem cells. The ester-type catechin (EGCG) can enhance the ability of fat stem cells and increase the ability of fat stem cells to repair damaged tissues .